Case Report: Two Cases of Persistent Hiccups Complicating COVID-19

Am J Trop Med Hyg. 2021 Apr 1;104(5):1713-1715. doi: 10.4269/ajtmh.21-0190.

Abstract

Two cases are presented with coronavirus disease 19 (COVID-19)-related hiccups: one during initial presentation and one 10 days after COVID-19 diagnosis. Hiccups in both patients were resistant to treatment and responded only to chlorpromazine. COVID-19 patients may present with hiccups and also may have hiccups after treatment. Resistant hiccups without any underlying disease other than COVID-19 should be considered in association with COVID-19 and may respond well to chlorpromazine.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 / complications*
  • Chlorpromazine / therapeutic use
  • Hiccup / drug therapy
  • Hiccup / etiology*
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2*

Substances

  • Chlorpromazine